Sign up to save your podcasts
Or
Share Advancements in Biotech and Healthcare Sectors: CNS Pharmaceuticals, Calidi Biotherapeutics, and NanoViricides Updates
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Advancements in Biotech and Healthcare Sectors: CNS Pharmaceuticals, Calidi Biotherapeutics, and NanoViricides Updates
CNS Pharmaceuticals Inc. is concentrating on its Berubicin trial while advancing TPI 287 for glioblastoma treatment. Calidi Biotherapeutics and NanoViricides Inc. are making strides in AI screening for lung cancer and antiviral programs, respectively. These companies are actively pursuing innovative solutions in their respective fields to address critical healthcare needs.
View all episodes
CNS Pharmaceuticals Inc. is concentrating on its Berubicin trial while advancing TPI 287 for glioblastoma treatment. Calidi Biotherapeutics and NanoViricides Inc. are making strides in AI screening for lung cancer and antiviral programs, respectively. These companies are actively pursuing innovative solutions in their respective fields to address critical healthcare needs.